HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of fixed low dose hydroxyurea in Indian children with sickle cell anemia: a single centre experience.

AbstractINTRODUCTION:
Data on the efficacy of hydroxyurea (HU) in Indian children with sickle cell anaemia (SCA) is limited. Hence, we have evaluated the efficacy of fixed low dose HU in Indian children.
METHODS:
The study cohort consisted of 144 children (<18 years of age) with SCA having severe manifestations (≥ 3 episodes of vasocclusive crisis or blood transfusions, or having ≥ 1 episode of acute chest syndrome or cerebrovascular stroke or sequestration crisis) who were started on fixed low dose HU (10 mg/kg/day). They were followed up for two years and monitored for the hematological and clinical efficacy and safety.
RESULTS:
There was significant increase in the fetal hemoglobin level (HbF%), total hemoglobin and mean corpuscular volume. Vasoocclusive crises, blood transfusions, acute chest syndrome, sequestration crises and hospitalizations decreased significantly. Baseline HbF% had significant positive correlation with HbF% at 24 months. There was significant negative correlation between baseline HbF% and change in HbF% from baseline to 24 months. No significant correlation was found between HbF% at baseline and clinical event rates per year after HU. No major adverse events occurred during the study period.
CONCLUSIONS:
Fixed low dose HU is effective and safe in Indian children with SCA.
AuthorsDipti L Jain, Mohini Apte, Roshan Colah, Vijaya Sarathi, Saumil Desai, Amruta Gokhale, Amol Bhandarwar, Harshwardhan L Jain, Kanjaksha Ghosh
JournalIndian pediatrics (Indian Pediatr) Vol. 50 Issue 10 Pg. 929-33 (Oct 2013) ISSN: 0974-7559 [Electronic] India
PMID23798623 (Publication Type: Journal Article)
Chemical References
  • Antisickling Agents
  • Hydroxyurea
Topics
  • Adolescent
  • Anemia, Sickle Cell (blood, drug therapy)
  • Antisickling Agents (administration & dosage)
  • Child
  • Child, Preschool
  • Cohort Studies
  • Female
  • Hematologic Tests
  • Humans
  • Hydroxyurea (administration & dosage)
  • India
  • Longitudinal Studies
  • Male
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: